Kynam Capital Management, LP Caribou Biosciences, Inc. Call Options Transaction History
Kynam Capital Management, LP
- $1.22 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
137Shares Held
52.6MCall Options Held
148KPut Options Held
70.7K-
Black Rock Inc. New York, NY6.95MShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$7.25 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$7.18 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$6.76 Million0.49% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.13MShares$3.35 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $95.5M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...